Cancer risk

Some people with MDS go on to develop acute myeloid leukaemia (AML) , which is cancer of the white blood cells. This is known as "transformation".

According to Cancer Research UK, the risk varies from five in every 100 cases (5%) to 65 out of every 100 cases (65%), depending on the type of MDS you have. It can take a few months or up to several years before transformation takes place.

Ask your doctor about your risk of developing AML.

Content supplied by the NHS Website

Medically Reviewed by a doctor on 21 Dec 2018